Year-end Sale % OFF 
Abstract
For the first time since bisacodyl was licensed in the 1950s, an up-to-date review has provided a thorough summary of the pharmacological and clinical data concerning this prokinetic and secretagogic laxative. On the basis of the knowledge gained after numerous years of experience with the drug, the review derives practical guidance on advising patients to ensure an even more effective and safer use of bisacodyl.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
